Enhancing T Cell Function with Mitochondria Boosts Cancer Immunotherapy

1 min read
Source: The Jerusalem Post
TL;DR

Researchers from Hebrew University of Jerusalem and international partners have discovered a method to enhance the immune system's ability to fight cancer by reprogramming T cells through the inhibition of the mitochondrial protein Ant2, which improves their energy production, resilience, and effectiveness against tumors, with potential for clinical application using drugs.

Share this article

Want the full story? Read the original reporting

Read on The Jerusalem Post